| 发明名称 |
NEW TREATMENTS FOR NERVOUS DISORDERS |
| 摘要 |
<p>Reboxetine is a selective noradrenaline reuptake inhibitor and does not affect other neurotransmitters. Use of reboxetine for treating obsessive compulsive disorder (OCD) and/or panic disorder(PD), is new. ACTIVITY : Antidepressant. MECHANISM OF ACTION : (I) is a specific inhibitor of noradrenaline reuptake.</p> |
| 申请公布号 |
SI1071418(T1) |
申请公布日期 |
2005.04.30 |
| 申请号 |
SI19990030684T |
申请日期 |
1999.04.02 |
| 申请人 |
PHARMACIA ITALIA S.P.A.;PHARMACIA & UPJOHN COMPANY |
发明人 |
DUBINI ADRIANA;MCCALL JOHN MICHAEL;TAYLOR DUNCAN PAUL;VON VOIGTLANDER PHILIP F.;WONG ERIK HO FONG |
| 分类号 |
A61K;A61K31/00;A61K31/35;A61K31/5375;A61P25/00;A61P25/22;(IPC1-7):A61K31/537 |
主分类号 |
A61K |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
